Amplification of the meningococcal porB gene for non-culture serotype characterization

Epidemiology and Infection

Volumn 120, Issue 3, 1998, Pages 257-262

  Urwin, R ^a,b   Kaczmarski, E B ^a   Guiver, M ^a   Fox, A J ^a   Maiden, M C J ^b  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BACTERIUM ISOLATION; CEREBROSPINAL FLUID; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MOLECULAR HYBRIDIZATION; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; SEROTYPING; UNITED KINGDOM;

EID: 0031869898     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268898008656     Document Type: Article

References (25)

1. Kaczmarski EB. Meningococcal infections in England and Wales. CDR Rev 1997; 7: R55-9.
2. Cartwright KAV, Reilly S, White DA, Stuart JM. Early treatment with parenteral penicillin in meningococcal disease. BMJ 1992; 305: 143-7.
3. Wylie PAL, Stevens D, Drake W, Stuart J, Cartwright KAV. Epidemiology and clinical management of meningococcal disease in west Gloucestershire; retrospective, population based study. BMJ 1997; 315: 774-9.
4. Hart CA, Rogers TRF. Meningococcal disease. J Med Microbiol 1993; 39: 3-25.
5. Kristiansen B-E, Ask E, Jenkins A, Fermér C, Rådstrøm P, Sköld O. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 1991; 337: 1568-9.
6. Ni H, Knight AI, Cartwright KAV, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal infection. Lancet 1992; 340: 1432-4.
7. Rådstrøm P, Backman A, Qian N, Kragsbjerg P, Pahlson C, Olcén P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994; 32: 2738-44.
8. Davison E, Borrow R, Guiver M, Kaczmarski EB, Fox AJ. The adaptation of the IS1106 PCR to a PCR ELISA format for the diagnosis of meningococcal infection. Serodiagn Immunother 1996; 8: 51-6.
9. Borrow R, Claus H, Guiver M, et al. Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect 1997; 118: 111-7.
10. Caugant FA, Høiby EA, Frøholm LO, Brandtzaeg P. Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian serogroup B protection trial. Scand J Infect Dis 1996; 28: 149-53.
11. Saunders NB, Zollinger WD, Rao VB. A rapid and sensitive PCR strategy employed for amplification and sequencing of por A from a single colony-forming unit of Neisseria meningitidis. Gene 1993; 137: 153-62.
12. Poolman JT, Lind I, Jonsdottir K, Froholm LO, Jones DM, Zanen HC. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet 1986; ii: 555-7.
13. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-71.
14. Guttormsen H-K. Bjerknes R, Halstensen A, Naess A, Hoiby EA, Solberg CO. Cross-reacting serum opsonins to meningococci after vaccination. J Infect Dis 1993; 167: 1314-9.
15. Bjune G, Høiby EA, Gronnesby JK, et al. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 1991; 338: 1093-6.
16. Sierra GVG, Campa HC, Varcacel NM, et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 1991; 14: 195-207.
17. Zollinger WD, Boslego J, Moran E, et al. Meningococcal serogroup B vaccine protection trial and followup studies in Chile. The Chilean National Committee for Meningococcal Disease. NIPH Ann 1991; 14: 211-2.
18. Maiden MCJ, Suker J, McKenna AJ, Bygraves JA, Feavers IM. Comparison of the class I outer membrane proteins of eight serological reference strains of Neisseria meningitidis. Mol Microbiol 1991; 5: 727-36.
19. van der Ley P, Heckels JE, Virji M, Hoogerhout P, Poolman JT. Topology of outer membrane proteins in pathogenic Neisseria species. Infect Immun 1991; 59: 2963-71.
20. Bash MC, Lesiak KB, Banks SD, Frasch CE. Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques. Infect Immun 1995; 63: 1484-90.
21. Feavers IM, Suker J, McKenna AJ, Heath AB, Maiden MCJ. Molecular analysis of the serotyping antigens of Neisseria meningitidis. Infect Immun 1992; 60: 3620-9.
22. Jones DM, Kaczmarski EB. Meningococcal infections in England and Wales. CDR Rev 1995; 2: R125-30.
23. Wang J-F, Caugant DA, Morelli G, Koumaré B, Achtman M. Antigenic and epidemiological properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis 1993; 167: 1320-9.
24. Poolman JT, Kriz Kuzemenska P, Ashton F, et al. Serotypes and subtypes of Neisseria meningitidis: esults of an international study comparing sensitivities and specificities of monoclonal antibodies. Clin Diagn Lab lmmunol 1995; 2: 69-72.
25. Wedege E, Caugant DA, Frøholm LO, Zollinger WD. Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis. J Clin Microbiol 1993; 29: 1486-92.